AU2003233998A1 - Ddah modulators in the treatment of pain - Google Patents
Ddah modulators in the treatment of painInfo
- Publication number
- AU2003233998A1 AU2003233998A1 AU2003233998A AU2003233998A AU2003233998A1 AU 2003233998 A1 AU2003233998 A1 AU 2003233998A1 AU 2003233998 A AU2003233998 A AU 2003233998A AU 2003233998 A AU2003233998 A AU 2003233998A AU 2003233998 A1 AU2003233998 A1 AU 2003233998A1
- Authority
- AU
- Australia
- Prior art keywords
- ddah
- modulators
- pain
- treatment
- ddah modulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101100169989 Rattus norvegicus Ddah1 gene Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0211297.7 | 2002-05-16 | ||
GBGB0211297.7A GB0211297D0 (en) | 2002-05-16 | 2002-05-16 | Pain treatment |
PCT/GB2003/002088 WO2003097084A1 (en) | 2002-05-16 | 2003-05-15 | Ddah modulators in the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003233998A1 true AU2003233998A1 (en) | 2003-12-02 |
Family
ID=9936850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003233998A Abandoned AU2003233998A1 (en) | 2002-05-16 | 2003-05-15 | Ddah modulators in the treatment of pain |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003233998A1 (en) |
GB (1) | GB0211297D0 (en) |
WO (1) | WO2003097084A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100278937A1 (en) * | 2005-10-06 | 2010-11-04 | Das Gupta Tapas K | Compositions and methods to prevent and/or treat cancer with pa-card |
WO2020012545A1 (en) * | 2018-07-10 | 2020-01-16 | オリンパス株式会社 | Phototherapy assistance device, phototherapy system and phototherapy assistance method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1144605B1 (en) * | 1999-01-26 | 2009-12-16 | University College London | Dimethylarginine dimethylaminohydrolases |
US20030138803A1 (en) * | 2001-07-27 | 2003-07-24 | Brooksbank Robert Alan | Identification and use of molecules implicated in pain |
-
2002
- 2002-05-16 GB GBGB0211297.7A patent/GB0211297D0/en not_active Ceased
-
2003
- 2003-05-15 AU AU2003233998A patent/AU2003233998A1/en not_active Abandoned
- 2003-05-15 WO PCT/GB2003/002088 patent/WO2003097084A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003097084A1 (en) | 2003-11-27 |
GB0211297D0 (en) | 2002-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003202196A1 (en) | Devices and methods for heart valve treatment | |
AU2003216162A1 (en) | Iontophoretic treatment device | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
AU2003283257A1 (en) | Scalp treatment | |
AU2003202075A1 (en) | Modulator of the notch signalling pathway and use thereof in medical treatment | |
AU2002357830A1 (en) | Methods and devices for therapeutic treatment cardiac and other pathologies | |
AU2003226537A1 (en) | Modulators of the notch signalling pathway and uses thereof in medical treatment | |
AU2003227944A1 (en) | Ddah modulators in the treatment of pain | |
GB0213869D0 (en) | The treatment of pain | |
AU2002319286A1 (en) | Skin treatment | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
AU2003293500A1 (en) | Lactoferrin in the reduction of pain | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003233998A1 (en) | Ddah modulators in the treatment of pain | |
AU2003268939A1 (en) | Bisphosphonates for the treatment of antheroscleorosis and devices comprising them | |
AU2003275433A1 (en) | Compositions and methods for treating pain | |
AU2003240446A1 (en) | Use of mob-5 in pain | |
AU2003904303A0 (en) | Nerve function and tissue healing | |
AU2003217432A1 (en) | Angiopoietin-1 in the treatment of disease | |
AU2003273817A1 (en) | Increasing of the resorption of substances via skin and mucous membranes | |
AU2003215725A1 (en) | Materials and methods relating to the treatment of lymphoma | |
AU2003293714A1 (en) | Methods for the treatment of chronic pain and compositions therefor | |
AU2002324184A1 (en) | Use of a lentiviral vector in the treatment of pain | |
GB0325957D0 (en) | The treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |